New Discussion Topics Include Rapid Response Management and FDA Special Protocol Assessment Development
Online PR News – 26-February-2014 – Chicago, IL – (Chicago, IL) – For the third consecutive year, Q1 Productions will be hosting the Regulatory Writing and Submission Conference on May 8-9, 2014 in Alexandria, Virginia, offering medical and regulatory writers and submissions specialists an opportunity to meet with the industry’s biggest names and receive the most relevant information pertaining to today’s international regulatory industry.
Conference topics will include hyperlinking and bookmarking best practices, the use of tables and graphs in medical writing, and the best practices for metrics and reporting methods. Sessions and panel discussions will be covered by distinguished presenters including Cathy Cummins of Novartis, Aaron Bernstein of Warner Chilcott, Fran Quinn of Pfizer, and Peter Jons of Medimmune.
“This conference illustrates the importance of collaboration and how to facilitate it,” said conference speaker Marissa Sullivan of Olympus Biotech. “This is an opportunity for attendees to share experiences and best practices for future endeavors.”
By popular request, this year’s conference will offer highly specialized breakout sessions based on company size, providing the most applicable resources regarding software systems and strategic outsourcing and vendor management trends. Attendees will have the opportunity network with peers and learn how to combat some of the biggest concerns within the regulatory writing industry.
For more information or to register for the 3rd Annual Regulatory Writing and Submission Conference, or any other Q1 Productions events, please visit http://www.q1productions.com/regulatorywriting.
Follow us: @Q1Productions #q1regwrit
About the Organizer
Q1 Productions designs and develops webinars, training courses, conference programs and forums aimed at specifically targeted audiences throughout highly regulated industries in order to provide strategic learning and timely program content. Through a highly structured production process focused on research calls with end-users and key stakeholders in the industry, our team is able to understand the immediate business concerns of today’s leading executives. Whether focusing on new or pending legislative and health policy issues or enhanced technologies or processes that will drive efficiency, our programs provide solutions to the urgent educational and information needs of our attendees.